Using a sensitive luciferase immunoprecipitation system (LIPS) to detect HTLV-I/II seroindeterminates in Jamaica by Akahata, Yoshimi et al.
MEETING ABSTRACT Open Access
Using a sensitive luciferase immunoprecipitation
system (LIPS) to detect HTLV-I/II
seroindeterminates in Jamaica
Yoshimi Akahata
1, Anna Abrams
1, Elizabeth Maloney
2, Matthew McCormick
1, Steven Jacobson
1*
From 15th International Conference on Human Retroviruses: HTLV and Related Viruses
Leuven and Gembloux, Belgium. 5-8 June 2011
Human T-cell Leukemia Virus type I (HTLV-I) infects
an estimated 15-20 million persons worldwide. A num-
ber of diseases have been associated with this virus
including adult T-cell leukemia/lymphoma (ATLL),
HTLV-associated myelopathy/tropical spastic parapar-
esis (HAM/TSP), HLTV-I uveitis, and HTLV-I–asso-
ciated infective dermatitis. The screening process for
HTLV-I among blood banks includes detection by an
enzyme immunoassay (EIA) followed by a confirmatory
western blot (WB). Seropositive results are defined by
the presence of all core bands (p19, p24, and p53) as
well as the band specific for recombinant HTLV-I Env
glycoprotein. However, numerous cases have been docu-
mented in which a positive response was detected by
ELISA, but WB displayed an incomplete banding pat-
tern. These samples were then categorized as seroinde-
terminates. Using the LIPS assay, 60% of the 53
seroindeterminate samples previously screened by
ELISA and WB displayed anti-HTLV-I Gag, Env or Tax
antibody responses (based on 2 standard deviations
above the mean value for the HTLV-I negative group).
The LIPS assay was also able to detect anti-HTLV-I
antibody responses in 6% of the 167 samples determined
to be HTLV-I ELISA negative. A number of these sam-
ples were subsequently found to have an indeterminate
WB pattern. Although the significance of these HTLV-I/
II seroindeterminates is unclear, it may suggest a much
higher prevalence of exposure to HTLV-I/II than pre-
viously estimated, as seroindeterminate samples may
indicate exposure to the virus. The LIPS assay is a sensi-
tive and high throughput antibody detection assay which
may prove to be a useful tool in HTLV-I related clinical
investigations.
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